These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16678160)

  • 1. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
    Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
    Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
    Schmitt HP
    Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW; McNaught KS
    Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rings, chains and ladders: ubiquitin goes to work in the neuron.
    Johnston JA; Madura K
    Prog Neurobiol; 2004 Jul; 73(4):227-57. PubMed ID: 15261394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
    Fornai F; Soldani P; Lazzeri G; di Poggio AB; Biagioni F; Fulceri F; Batini S; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 Apr; 65(4):275-90. PubMed ID: 15811592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
    Tai HC; Schuman EM
    Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
    Fornai F; Lazzeri G; Bandettini Di Poggio A; Soldani P; De Blasi A; Nicoletti F; Ruggieri S; Paparelli A
    Ann N Y Acad Sci; 2006 Aug; 1074():84-9. PubMed ID: 17105905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
    Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
    Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks.
    Mittal S; Ganesh S
    Neurosci Res; 2010 Nov; 68(3):159-66. PubMed ID: 20708043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.